Evidence map›Paper›PMID 35036081›Full record

ArticlePeerJ2022

Key genes associated with prognosis and metastasis of clear cell renal cell carcinoma.

Tingting Zhong, Zeying Jiang, Xiangdong Wang, Honglei Wang, Meiyi Song, Wenfang Chen, Shicong Yang

Open access · goldAbstract read
In one paragraph

Article in PeerJ, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. [Molecular characteristics for poor prognosis related renal cell carcinoma with lymph metastases].Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2026
    Article
  2. The Duality of Collagens in Metastases of Solid Tumors.International journal of molecular sciences · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Tingting ZhongDepartment of Pathology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Zeying JiangDepartment of Pathology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Xiangdong WangDepartment of Pathology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Honglei WangDepartment of Pathology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Meiyi SongDepartment of Pathology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Wenfang ChenDepartment of Pathology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Shicong YangDepartment of Pathology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Sun Yat-sen University · CNThe First Affiliated Hospital, Sun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundClear cell renal cell carcinoma (ccRCC) is a tumor that frequently shows the hematogenous pathway and tends to be resistant to radiotherapy and chemotherapy. However, the exact mechanism of ccRCC metastasis remains unknown.

methodsDifferentially expressed genes (DEGs) of three gene expression profiles (GSE85258, GSE105288 and GSE22541) downloaded from the Gene Expression Omnibus (GEO) database were analyzed by GEO2R analysis, and co-expressed DEGs among the datasets were identified using a Venn drawing tool. The co-expressed DEGs were investigated using Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis, and hub genes were determined based on the protein-protein interaction network established by STRING. After survival analysis performed on UALCAN website, possible key genes were selected and verified in ccRCC cell lines and ccRCC tissues (

resultsA total of 104 co-expressed DEGs were identified in the three datasets. Pathway analysis revealed that these genes were enriched in the extracellular matrix (ECM)-receptor interaction, protein digestion and absorption and focal adhesion. Survival analysis on 17 hub genes revealed that four key genes with a significant impact on survival: procollagen C-endopeptidase enhancer (

conclusionPCOLCE, P4HB, COL6A2 and COL6A3 are upregulated in metastatic ccRCC and might be related to poor prognosis and distant metastases.

Indexed as

CarcinomaCarcinoma, Renal CellKidney NeoplasmsBiomarkers, TumorCollagen Type VIGene Expression ProfilingHumansPrognosisRNA, MessengerBiomarkers, TumorCollagen Type VIRNA, MessengerClear cell renal cell carcinomaCOL6A2COL6A3MetastasisP4HBPCOLCE

Identifiers

PMID35036081
PMCPMC8740509
OpenAlexW4225853659

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.